MEEDER ASSET MANAGEMENT INC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 79 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,329
+33.4%
3,8170.0%0.00%
Q2 2023$5,496
-31.4%
3,8170.0%0.00%
-100.0%
Q1 2023$8,016
+85.9%
3,8170.0%0.00%
Q4 2022$4,313
-52.1%
3,817
-32.3%
0.00%
-100.0%
Q3 2022$9,000
+28.6%
5,635
-5.4%
0.00%
Q2 2022$7,000
-46.2%
5,957
-25.5%
0.00%
-100.0%
Q1 2022$13,000
-56.7%
7,994
+2.7%
0.00%
-50.0%
Q3 2021$30,000
+87.5%
7,783
+58.3%
0.00%
+100.0%
Q2 2021$16,0004,917
+2543.5%
0.00%
Q1 2020$0186
+878.9%
0.00%
Q3 2019$0190.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$565,0000.18%
D.A. DAVIDSON & CO. 851,101$2,604,0000.05%
Iron Gate Global Advisors LLC 17,090$52,0000.02%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$37,0000.02%
IHT Wealth Management, LLC 28,155$86,0000.01%
OSAIC HOLDINGS, INC. 1,012,430$3,098,0000.01%
Ameritas Investment Company, LLC 10,782$33,0000.01%
Vivaldi Capital Management LP 15,439$40,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$48,0000.01%
Geneos Wealth Management Inc. 37,017$108,0000.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders